Famotidine: Is it a potential new candidate for the treatment of schizophrenia by inhibiting GSK-3 beta?

Unal G., Dokumaci A. H., Hazar-Yavuz A. N., Aycan M. B., Sahin C., Keles R., ...More

29th Congress of the European-College-of-Neuropsychopharmacology (ECNP), Vienna, Austria, 17 - 20 September 2016, vol.26, (Summary Text)

• Publication Type: Conference Paper / Summary Text
• Volume: 26
• Doi Number: 10.1016/s0924-977x(16)31560-7
• City: Vienna
• Country: Austria
• Marmara University Affiliated: Yes